News

This morning San Luis Obispo-based wellness platform Mindbody announced the acquisition of FitMetrix, a performance tracking engagement platform, for an undisclosed sum.

Palo Alto, California-based Cognoa’s machine learning app for pediatric behavioral health has received categorization from the FDA as a diagnostic medical device for autism, according to an announcement from the company.

New York and Palo Alto, California-based MemoryMD has received FDA clearance for NeuroEEG, a wireless amplifier that transmits EEG signals to computers and cloud-based databases via Bluetooth.

Roche’s Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA.

Optra Health, which produces AI-driven iPhronesis analysis platform for healthcare and life sciences clients, today announced the launch of a new genetics-focused product specially designed for consumers, genetic counselors, and other genomics researchers.

The University of Pennsylvania's Penn Medicine has been an active player in the telehealth game for sometime with multiple telehealth units, but last week it went a step further to announce that it will be centralizing its telemedicine activities into the Penn Medicine Center for Connected Care.

OrCam, an Israeli company working on augmented reality for the blind and vision impaired, has raised $30.

Researchers from Microsoft are aiming to transform the world of virtual reality from a primarily visual experience to a tactile and auditory one for people with visual impairments.

With so many innovative ideas circulating, conference attendees are hard-pressed to cover all of it.

Google AI has made a breakthrough: successfully predicting cardiovascular problems such as heart attacks and strokes simply from images of the retina, with no blood draws or other tests necessary.